Previous 10 | Next 10 |
Extends reach of MonolixSuite™ to China’s growing pharmacology market Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today ann...
New distribution channel will accelerate adoption of software and services in emerging markets Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries...
Facilitates Access to KIWI TM , a Pharmacometrics Modeling and Simulation Platform Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that its Cognigen divis...
Health care industry software and consulting provider Simulations Plus (NASDAQ: SLP) posted impressive results in the first quarter of its fiscal year 2021, continuing a trend that pushed this small-cap dynamo's stock up 147% last year. Results, however, fell largely in line with an...
The following slide deck was published by Simulations Plus, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Simulations Plus, Inc. 2021 Q1 - Results - Earnings Call Presentation
Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will present at the 23 rd Annual Needham Virtual Grow...
Integrated machine learning and PBPK/PD methods will support discovery and development activities Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries,...
Simulations Plus, Inc. (SLP) Q1 2021 Earnings Conference Call January 11, 2021 04:15 PM ET Company Participants Cameron Donahue - IR Shawn O'Connor - CEO Will Frederick - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Francois Brisebois - Oppenheimer David Larsen - BTIG Dave Wind...
Image source: The Motley Fool. Simulations Plus Inc (NASDAQ: SLP) Q1 2021 Earnings Call Jan 11, 2021 , 4:15 p.m. ET Operator Continue reading For further details see: Simulations Plus Inc (SLP) Q1 2021 Earnings Call Transcript
New modeling approaches will accelerate the evaluation of innovative formulation strategies Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today...
News, Short Squeeze, Breakout and More Instantly...
Objective to define best practices for the use of novel PBK modeling strategies to support animal-free safety assessment of new chemicals Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance an...
Total revenue of $18.5 million and diluted earnings per share (EPS) of $0.15 Maintains full-year revenue guidance of $69 to $72 million and updates EPS guidance Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulati...
2024-06-24 16:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...